Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies

Pediatric gliomas (PGs) are the most common brain tumors in children and the leading cause of childhood cancer-related death. The understanding of the immune microenvironment is essential for developing effective antitumor immunotherapies. Transcriptomic data from 495 PGs were analyzed in this study...

Full description

Bibliographic Details
Main Authors: Zihao Wang, Xiaopeng Guo, Lu Gao, Yu Wang, Yi Guo, Bing Xing, Wenbin Ma
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Molecular Therapy: Oncolytics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770520301868
_version_ 1818460928638713856
author Zihao Wang
Xiaopeng Guo
Lu Gao
Yu Wang
Yi Guo
Bing Xing
Wenbin Ma
author_facet Zihao Wang
Xiaopeng Guo
Lu Gao
Yu Wang
Yi Guo
Bing Xing
Wenbin Ma
author_sort Zihao Wang
collection DOAJ
description Pediatric gliomas (PGs) are the most common brain tumors in children and the leading cause of childhood cancer-related death. The understanding of the immune microenvironment is essential for developing effective antitumor immunotherapies. Transcriptomic data from 495 PGs were analyzed in this study, with 384 as a training cohort and 111 as a validation cohort. Macrophages were the most common immune infiltrates in the PG microenvironment, followed by T cells. PGs were classified into 3 immune subtypes (ISs) based on immunological profiling: “immune hot” (IS-I), “immune altered” (IS-II), and “immune cold” (IS-III). IS-I tumors, characterized by substantial immune infiltration and high immune checkpoint molecule (ICM) expression, had a favorable prognosis and were more likely to respond to anti-PD1 and anti-CTLA4 immunotherapies, whereas IS-III tumors, characterized by weak immune infiltration and low ICM expression, had a dismal prognosis and poor immunotherapy responsiveness. IS-II tumors represented a transitional stage. Immune classification was also correlated with somatic mutations, copy number alterations, and molecular pathways related to tumorigenesis, metabolism, and immune responses. Three predictive classifiers using eight representative genes were generated by machine learning methods for immune classification. This study established a reliable immunological profile-based classification system for PGs, providing implications for further immunotherapy strategies.
first_indexed 2024-12-14T23:38:03Z
format Article
id doaj.art-af8a326e0d2f47c4a3913458120a50a7
institution Directory Open Access Journal
issn 2372-7705
language English
last_indexed 2024-12-14T23:38:03Z
publishDate 2021-03-01
publisher Elsevier
record_format Article
series Molecular Therapy: Oncolytics
spelling doaj.art-af8a326e0d2f47c4a3913458120a50a72022-12-21T22:43:34ZengElsevierMolecular Therapy: Oncolytics2372-77052021-03-01203447Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategiesZihao Wang0Xiaopeng Guo1Lu Gao2Yu Wang3Yi Guo4Bing Xing5Wenbin Ma6Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Corresponding author: Bing Xing, Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Corresponding author: Wenbin Ma, Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.Pediatric gliomas (PGs) are the most common brain tumors in children and the leading cause of childhood cancer-related death. The understanding of the immune microenvironment is essential for developing effective antitumor immunotherapies. Transcriptomic data from 495 PGs were analyzed in this study, with 384 as a training cohort and 111 as a validation cohort. Macrophages were the most common immune infiltrates in the PG microenvironment, followed by T cells. PGs were classified into 3 immune subtypes (ISs) based on immunological profiling: “immune hot” (IS-I), “immune altered” (IS-II), and “immune cold” (IS-III). IS-I tumors, characterized by substantial immune infiltration and high immune checkpoint molecule (ICM) expression, had a favorable prognosis and were more likely to respond to anti-PD1 and anti-CTLA4 immunotherapies, whereas IS-III tumors, characterized by weak immune infiltration and low ICM expression, had a dismal prognosis and poor immunotherapy responsiveness. IS-II tumors represented a transitional stage. Immune classification was also correlated with somatic mutations, copy number alterations, and molecular pathways related to tumorigenesis, metabolism, and immune responses. Three predictive classifiers using eight representative genes were generated by machine learning methods for immune classification. This study established a reliable immunological profile-based classification system for PGs, providing implications for further immunotherapy strategies.http://www.sciencedirect.com/science/article/pii/S2372770520301868pediatric gliomaimmune classificationoverall survivalimmunotherapy responsivenesstumor microenvironment
spellingShingle Zihao Wang
Xiaopeng Guo
Lu Gao
Yu Wang
Yi Guo
Bing Xing
Wenbin Ma
Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
Molecular Therapy: Oncolytics
pediatric glioma
immune classification
overall survival
immunotherapy responsiveness
tumor microenvironment
title Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
title_full Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
title_fullStr Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
title_full_unstemmed Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
title_short Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
title_sort classification of pediatric gliomas based on immunological profiling implications for immunotherapy strategies
topic pediatric glioma
immune classification
overall survival
immunotherapy responsiveness
tumor microenvironment
url http://www.sciencedirect.com/science/article/pii/S2372770520301868
work_keys_str_mv AT zihaowang classificationofpediatricgliomasbasedonimmunologicalprofilingimplicationsforimmunotherapystrategies
AT xiaopengguo classificationofpediatricgliomasbasedonimmunologicalprofilingimplicationsforimmunotherapystrategies
AT lugao classificationofpediatricgliomasbasedonimmunologicalprofilingimplicationsforimmunotherapystrategies
AT yuwang classificationofpediatricgliomasbasedonimmunologicalprofilingimplicationsforimmunotherapystrategies
AT yiguo classificationofpediatricgliomasbasedonimmunologicalprofilingimplicationsforimmunotherapystrategies
AT bingxing classificationofpediatricgliomasbasedonimmunologicalprofilingimplicationsforimmunotherapystrategies
AT wenbinma classificationofpediatricgliomasbasedonimmunologicalprofilingimplicationsforimmunotherapystrategies